Stockholders' Equity (Tables)

12 Months Ended

Dec. 31, 2024

Equity [Abstract]

Summary of Restricted Stock and Restricted Stock Units Activity

The table below sets forth the restricted stock and restricted stock unit activity for the year ended December 31, 2022:

	Number of Shares	Weighted Average Grant Price and Fair Value
Non vested, December 31, 2021	506,787	$	27.68
Shares granted	617,830	20.10
Vested shares	(267,554)	27.29
Shares forfeited	(187,390)	24.20
Non vested, December 31, 2022	669,673	$	22.00

The table below sets forth the restricted stock and restricted stock unit activity for the year ended December 31, 2023:

	Number of Shares	Weighted Average Grant Price and Fair Value
Non vested, December 31, 2022	669,673	$	22.00
Shares granted	831,746	11.83
Vested shares	(319,225)	22.03
Shares forfeited	(130,030)	17.53
Non vested, December 31, 2023	1,052,164	$	14.74

The table below sets forth the restricted stock and restricted stock unit activity for the year ended December 31, 2024:

	Number of Shares	Weighted Average Grant Price and Fair Value
Non vested, December 31, 2023	1,052,164	$	14.74
Shares granted	595,976	10.71
Vested shares	(475,116)	14.89
Shares forfeited	(66,768)	14.60
Non vested, December 31, 2024	1,106,256	$	12.63

Summary of Status of Stock Incentive Plans and Changes During Periods

The table below sets forth stock option activity for the year ended December 31, 2022:

	Number of Options	Weighted Average Exercise Price		Weighted Average Contractual Life (years)	Aggregate Intrinsic Value
					(in thousands)
Outstanding, December 31, 2021	101,520	$	26.65	8.39	$	—
Options granted	56,249	13.90		10	$	—
Awards exercised	—	—
Options forfeited	(24,181)	27.99
Outstanding, December 31, 2022	133,588	$	21.04	8.09	$	37
Exercisable, December 31, 2022	58,782	$	25.19	6.59	$	—

The table below sets forth stock option activity for the year ended December 31, 2023:

	Number of Options	Weighted Average Exercise Price		Weighted Average Contractual Life (years)	Aggregate Intrinsic Value
					(in thousands)
Outstanding, December 31, 2022	133,588	$	21.04	8.09	$	37
Options granted	33,762	6.71		10	$	—
Awards exercised	—	—
Options forfeited	(3,968)	26.20
Outstanding, December 31, 2023	163,382	$	17.95	7.73	$	119
Exercisable, December 31, 2023	83,644	$	23.16	6.78	$	—

The table below sets forth stock option activity for the year ended December 31, 2024:

	Number of Options	Weighted Average Exercise Price		Weighted Average Contractual Life (years)	Aggregate Intrinsic Value
					(in thousands)
Outstanding, December 31, 2023	163,382	$	17.95	7.73	$	119
Options granted	—	—		—	$	—
Awards exercised	(5,796)	11.60
Options forfeited	(4,616)	5.36
Outstanding, December 31, 2024	152,970	$	18.57	6.64	$	799
Exercisable, December 31, 2024	116,332	$	21.10	6.25	$	397

Summary of Fair Value at the Date of Grant

	Year Ended December 31,
	2022			2023
Expected volatility	48.08		%	53.50		%
Expected dividends	—		%	—		%
Expected term, in years	10			10
Risk-free interest rate	2.95		%	3.49		%
Weighted-average fair value of options granted during the year	$	8.53		$	4.44

Summary of Stock-Based Compensation

For the years ended December 31, 2022, 2023, and 2024, the Company recognized stock-based compensation expense as follows:

	Year Ended December 31,
	2022		2023		2024
	(In thousands)
Instructional costs and services	$	1,254	$	895	$	808
Selling and promotional	823		490		562
General and administrative	5,932		6,355		6,298
Total stock-based compensation expense	$	8,009	$	7,740	$	7,668